Keratinocytes and cytokine/growth factors

Critical Reviews in Oral Biology and Medicine

Volumn 7, Issue 4, 1996, Pages 300-318

  Feliciani, C ^a   Gupta, A K ^b   Sauder, D N ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

chemokines; Cytokines; growth factors; oral mucosa

Indexed keywords

CHEMOKINE; COLONY STIMULATING FACTOR; CYTOKINE; CYTOKINE RECEPTOR; ERYTHROPOIETIN; GROWTH FACTOR; IMMUNOGLOBULIN; INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; BASAL CELL CARCINOMA; EPITHELIUM CELL; ETIOLOGY; HUMAN; IMMUNOREGULATION; INTRALESIONAL DRUG ADMINISTRATION; KAPOSI SARCOMA; KERATINOCYTE; LANGERHANS CELL; LICHEN PLANUS; MOUTH DISEASE; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; T CELL LYMPHOMA; VIRUS INFECTION; WOUND HEALING;

EID: 0030463464     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411960070040101     Document Type: Review

References (184)

1. Allavena P, Paganin C, Martin-Padura I, Peri G, Gabol M, Dejana E, et al. (1991). Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J Exp Med 173:439-448.
2. Ansel JC, Armstrong CA, Hart CE (1994). Platelet-derived growth factor. In: Epidermal growth factors and cytokines. Luger TA, Schwarz T, editors. New York: Marcel Dekker, pp. 273-289.
3. Aragane Y, Riemann H, Bharwai RS, Schwarz A, Sawada Y, Yamada H, et al. (1994). IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 153:5366-5372.
4. Arend WP, Welgus HG, Thompson RC, Eisenberg SP (1990). Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 85:1694-1697.
5. Armstrong CA, Ansel JC, Luger TA (1994). Melanocyte cell cytokines. In: Growth factors and cytokines. Luger TA, Schwarz T, editors. New York: Marcel Dekker, pp. 433-450.
6. Baggiolini M, Clark-Lewis I (1992). Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 1:97-101.
7. Barker JNWN, Sharma V, Mitra RS (1990). Marked synergism between tumor necrosis factor alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 85:605-609.
8. Barker JNWN, Jones ML, Swenson CL (1991). Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-γ. J Immunol 146:1192-1197.
9. Baumann H, Jahreis GP, Sauder DN, Koj A (1984). Human keratinocytes and monocytes release factors which regulate the synthesis of major acute phase plasma proteins in hepatic cells from man, rat and mouse. J Biol Chem 259:7331-7342.
10. Bauer EA, Cooper TW, Huang JS, et al. (1985). Stimulation of in vitro human skin collagenase expresison by platelet-derived growth factor. Proc Natl Acad Sci USA 82:4132-4138.
11. Becker J, Löning T, Reichart P, Hartmann N (1983). Oral lichen planus: Characterization of immunocompetent cells with hybridoma antibodies. J Oral Pathol Med 12:117-123.
12. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE (1991). Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α: functional consequences on cell mediated cytotoxicity. J Immunol 147:4398-4401.
13. Beissert S, Ullrich SE, Hosoi J, Granstein RD (1995). Supernatants from UVB radiation-exposed keratinocytes inhibit Langerhans cell presentation of tumor-associated antigens via IL-10 content. J Leuco Biol 58:234-240.
14. Bell TV, Harley CB, Stetsko DK, Sauder DN (1987). Expression of mRNA homologous to interleukin-1 in human epidermal cells. J Invest Dermatol 88:375-379.
15. Benito M, Lorenzo M (1993). Platelet derived growth factor/tyrosine kinase receptor mediated proliferation. Growth Regul 3:172-179.
16. Bergstresser PR, Cruz PD Jr, Takashima A (1993). Dendritic epidermal T-cells: lessons from mice for humans. J Invest Dermatol 100:80S-83S.
17. Beutler B, Cerami A (1990). Cachectin (tumor necrosis factor): an endogenous mediator of shock and inflammatory response. In: Immunophysiology; the role of cells and cytokines in immunity and inflammation. Oppenheim JJ, Shevach EM, editors. New York: Oxford University Press, pp. 226-237.
18. Billiau A (1987). Interferon-2 as a promoter of growth and differentiation of B cells. Immunol Today 8:84-87.
19. Bischoff SC, Krieger M, Brunner T, Rot A, von Tscharner Baggiolini M, et al. (1993). RANTES and related chemokines activate human basophil granulocytes through different G protein coupled receptors. Eur J Immunol 23:761-767.
20. Blanchard DK, Michelini-Norris MB, Djeu JY (1991). Production of granulocyte-macrophage colony stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood 77:2259-2265.
21. Blanton RA, Kupper TS, McDougall JK (1989). Regulation of interleukin-1 and its receptor in human keratinocytes. Proc Natl Acad Sci USA 86:1273-1280.
22. Boorsma DM, Flier C, de Haan P, Stoof TJ (1993). Kinetics of HuGRO gIP-10 and IL-8 gene in cultured normal human keratinocytes (abstract). J Invest Dermatol 100:439.
23. Bordoni R, Fine RM, Murray D, et al. (1990). Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes and malignant melanocytes. J Cell Biol 44:207-219.
24. Boyan LA, Bhargava G, Nishimura F, Orman R, Price R, Terranova VP (1994). Mitogenic and chemotactic responses of human peridontal ligament cells to the different isoforms of platelet-derived growth factor. J Dent Res 73:1593-1600.
25. Brown IF, Yeo KT, Berse B (1992). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 176:1375-1379.
26. Carpenter G, Wahl M (1990). The epidermal growth factor family. In: Peptide growth factors and their receptors. Sporn MB, Roberts A, editors. New York: Springer Verlag.
27. Caux C, Dezutter-Dambuyant C, Schmitt D, Bancherau J (1992). GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360:258-261.
28. Chen G, Wilson R, McKillop JH, Walker JJ (1994). The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells. Immunol Invest 23:269-279.
29. Chihara J, Gruart V, Plumas J, Tavernier J, Kusnier JP, Prin L, et al. (1992). Induction of CD23, CD25, and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3, granulocyte/macrophage colony stimulating factor and interleukin-5. Eur Cytokine Netw 3:53-61.
30. Clark SC, Kamen R (1987). The human hematopoietic colony stimulating factors. Science 236:1229-1232.
31. Coffey R Jr, Derynck R, Wilcox J (1987). Production and auto-induction of transforming growth factor-α in human keratinocytes. Nature 328:817-820.
32. Collins T, Lapierre LA, Fiers W, Strominger JL, Pober JS (1986). Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 83:446-451.
33. Conti P, Panara MR, Porrini AM, Gambi D, Barbacane RC, Reale M, et al. (1992). Inhibition of interleukin-1 (alpha and beta), interleukin-2 secretion and surface expression of interleukin-2 receptor (IL-2R) by a novel cytokine interleukin-1 receptor antagonist (IL-1ra). Scand J Immunol 36:27-33.
34. 3H]-5HT-release. Immunology 86:434-440.
35. Cook PW, Coffey RJ, Magun BE (1990). Expression and regulation of mRNA encoding for acidic and basic fibroblast growth factor and transforming growth factor type-alpha in cells derived from human skin. Molec Endocrinol 4: 1377-1385.
36. Cork MJ, Duff GW (1994). Interleukin 1. In: Epidermal growth factors and cytokines. Luger TA, Schwarz T, editors. New York: Marcel Dekker, pp. 19-48.
37. Czek W, Krutmann J, Budnik A, Schopf E, Kapp A (1993). Induction of intercellular adhesion molecule 1 (ICAM-1) expression in normal human eosinophils by inflammatory cytokines. J Invest Dermatol 100:417-423.
38. Dalloul A, Laroche L, Bagot M (1992). Interleukin-7 is a growth factor for sezary lymphoma cells. J Clin Invest 90:1054-1060.
39. Deloron P, Chougnet C, Lepers JP, Tallet S, Coulanges P (1991). Protective value of elevated levels of gamma interferon in serum against exoerythrocytic stages of Plasmodium falciparum. J Clin Microbiol 29:1757-1760.
40. Deroq JM, Segui M, Poinot CC, Minty A, Caput D, Ferrara P, et al. (1994). Interleukin-13 stimulates interleukin-6 production by human keratinocytes. Similarity with interleukin-4. FEBS Lett 343:32-36.
41. Dexter TM (1989). Haematopoietic growth factors. Br Med Bull 45:337-349.
42. Di Marco E, Marchisio PC, Bondanza S, Franzi AT, Cancedda R, De Luca M (1991). Growth regulated synthesis and secretion of biologically active nerve growth factor by human keratinocytes. J Biol Chem 266:21718-21722.
43. Dinarello CA (1985). An update on human interleukin-1 from molecular biology to clinical relevance. J Clin Immunol 5:287-297.
44. Dinarello CA (1988). Interleukin-1 and its biologically related cytokines. FASEB J 2:108-185.
45. Dinarello CA (1989). Interleukin-1 and its biologically related cytokines. Adv Immunol 124:153-205.
46. Dinarello CA, Thompson RC (1991). Blocking IL-1: Interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 12:404-410.
47. Dinarello CA, Rosenwasser LJ, Wolff SM (1981). Demonstration of a circulating suppressor factor of thymocyte proliferation during endotoxic fever in humans. J Immunol 127:2517-2519.
48. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay IS, et al. (1992). Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony stimulating factor in the nasal mucosa after local allergen provocation relationship to tissue eosinophilia. J Immunol 148:2390-2394.
49. Dustin ML, Rothlein R, Bhan AK (1986). Induction by IL-1 and IFN-γ: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 137:245-247.
50. Enk CD, Sredni D, Blauvelt A, Katz SI (1995). Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 154:4851-4856.
51. Ensoli B (1989). AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth factor. Science 243:223-224.
52. Falanga V (1987). Transforming growth factor beta: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol 89:100-105.
53. Favre C, Saeland S, Caux C, Duvert V, DeVries JE (1990). Interleukin-4 has basophilic and eosinophilic cell growth promoting activity on cord blood cells. Blood 75:67-73.
54. Feliciani C, Amerio P, Mohammad Pour S, Allegretti T, Proietto G, Carmela C, et al. (1995). IL-1α, IL-6 and TNF-α in cutaneous lesions of lupus erythematosus are inhibited by topical application of calcipotriol. Int J Immunopath Pharm 8:199-207.
55. Fiorentino DF, Zlotnik A, Viera P (1991), IL-10 acts on the antigen presenting cell to inhibit cytokine production by TH1 cells. J Immunol 146:3444-3451.
56. Gauldie J, Richards C, Harnish D, Landsdorp P, Baumann H (1987). Interferon 2/BSF2 shares identity with monocyte derived hepatocyte stimulating factor (HSF) and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251-7256.
57. Germann T, Rude E (1995). Interleukin-12. Arch Allergy Immunol 108:103-112.
58. Graeven U, Hyelyn M (1992). In vitro growth patterns of normal human melanocytes and melanocytes from different stages of melanoma progression. J Immunother 12:199-202.
59. Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Chernyavsky AI, Barabash TM (1990). Pemphigus and pemphigoid epidermocytes interfere with interleukin cascade reactions. J Clin Lab Immunol 32:137-141.
60. Granowitz EV, Porat T, Mier JW, Pribble JP, Stiles DM, Bloedow DC, et al. (1992). Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 4:353-360.
61. Gregory H (1985). In vivo aspects of urogastrone-epidermal growth factor. J Cell Sci 13:11-15.
62. Grossman RM (1989). Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86:6367-6377.
63. Halaban R, Moellman G (1994). Fibroblast growth factors. In: Epidermal growth factors and cytokines. Luger TA, Schwarz T, editors. New York: Marcel Dekker, pp. 273-289.
64. Hammerberg C, Arend WP, Fisher GJ (1992). Interleukin-1 receptor antagonist in normal and psoriatic epidermis. J Clin Invest 90:571-583.
65. Heldin CH (1989). Platelet-derived growth factors: a family of isomorphs that bind to two distinct receptors. Br Med Bull 45:453-464.
66. Hendler FJ, Ozanne BW (1984). Squamous cell cancers express increased EGF receptors. J Clin Invest 74:647-651.
67. Henney CS (1989). Interleukin-7: effects on early events in lymphopoiesis. Immunol Today 10:170-173.
68. Heufler C, Topar G, Grasseger A (1992). Interleukin-7 is produced by murine and human keratinocytes. J Exp Med 178:1109-1114.
69. Hirota J, Osaki T, Tatemoto Y (1990). Immunohistochemical staining of infiltrates in oral lichen planus. Pathol Res Pract 186:625-632.
70. Ishizaka T, Saito H, Hatake K, Dvorak AM, Leiferman KM, Arai N, et al. (1989). Preferential differentiation of inflammatory cells by recombinant human interleukins. Int Arch Allergy Appl Immunol 88:46-49.
71. Jacob CO (1988). Tumor necrosis factor-α in murine autoimmune lupus nephritis. Nature 331:356-357.
72. Kaplan G, Luster AD, Hancock G, Cohn ZA (1987). The expression of a gamma-interferon induced protein (IP-10) in delayed immune response in human skin. J Exp Med 166:1098-1109.
73. Kaplan G, Walsh G, Guido LS, Meyn P, Burkhardt RA, Abalos RM, et al. (1992). Novel responses of human skin to intradermal recombinant GM-CSF: Langerhans cell recruitment, keratinocyte growth and enhanced wound healing. J Exp Med 175:1717-1728.
74. Katz SI, Aiba S, Cavani A, Enk AH (1995). Early events in contact sensitivity. Adv Exp Med Biol 378:497-500.
75. Keller SR, Lamphere L, Lavan BE, Kuhne MR, Lienhard GE (1993). Insulin and IGF-1 signalling through the insulin receptor substrate 1. Molec Reprod Dev 35:346-351.
76. Kennedy MC, Rosenbaum JT, Brown J, Planck SR, Huang X, Armstrong CA, et al. (1995). Novel production of interleukin-1 receptor antagonist peptides in normal human cornea. J Clin Invest 95:82-88.
77. Kishimoto T (1989). The biology of interleukin-6. Blood 74:1-10.
78. Knudsen PJ, Dinarello CA, Strom TB (1987). Glucocorticoids inhibit transcriptional and post-transcriptional expression of IL-1 in U937 cells. J Immunol 139:4129-4134.
79. Koch F, Heufler C, Kampgen E, Schneeweiss D, Bock G, Schuler G (1990). Tumor necrosis factor alpha maintains the viability of murine epidermal Langerhans cells in culture, but in contrast to GM-CSF without inducing their functional maturation. J Exp Med 171:159-171.
80. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, et al. (1990). Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultaviolet light. J Exp Med 172:1609-1614.
81. Kondo S, Ciarletta A, Turner KJ, Sauder DN, McKenzie RC (1995). Failure to detect interleukin- (IL)-3 mRNA or protein in human keratinocytes: antibodies to granulocyte-macrophage colony stimulating factor or IL-6 (but not IL-3) neutralize "IL-3" bioactivity. J Invest Dermatol 104:335-339.
82. Krasagakis K, Garbe C, Zouboulis CC, Orfanos CE (1995). Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res 139:169-182.
83. Kristensen MS, Paludan K, Larsen CG, Zachariae OC, Deleuran BW, Jensen PKA, et al. (1991). Quantitative determination of IL-1a-induced IL-8 mRNA levels in cultured human keratinocytes, dermal fibroblasts, endothelial cells and monocytes. J Invest Dermatol 97:506-510.
84. Kupper TS, Ballard DW, Chua AO, McGuire IS, Flood PM, Horowitz MC, et al. (1986). Human keratinocytes contain mRNA indistinguishable from monocyte interleukin-1 alpha and beta mRNA. J Exp Med 164:2095-2100.
85. Kupper TS, May LT, Birchall N, Sehgal PB (1988a). Keratinocytes produce interleukin-6, a cytokine which can provide the 2nd signal in the activation of T-cells (abstract). J Invest Dermatol 90:578.
86. Kupper TS, Lee F, Coleman D, Chodakewitz J, Flood P, Horowitz M (1988b). Keratinocyte derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony stimulating factor (GM-CSF). J Invest Dermatol 91:185-190.
87. Larsen CG, Anderson AO, Oppenheim U, Matsushima K (1989). Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. Immunology 68:31-36.
88. Le J, Villick J (1987). Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 56:234-248.
89. Leonard EJ, Yoshimura T, Tanaka S, Raffeld M (1991). Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. J Invest Dermatol 96:690-694.
90. Levi-Montalcini R (1987). The nerve growth factor 35 years later. Science 237:1154-1162.
91. Levin MI, Judson FN, Eron L (1989). Comparison of intramuscular recombinant interferon α (rIFN-2α) with topical Acyclovir for the treatment of first episode herpes genitalis and prevention of recurrences. Antimicrob Agents Chemother 33:649-652.
92. Longley J, Rochester C, Tyrrel L, Einarsson O, Elias J (1993). Interleukin-11 (IL-11) in normal skin and sarcoidosis (abstract). J Invest Dermatol 100:524.
93. Luger TA, Schwarz T (1991). Therapeutic use of cytokines in dermatology. J Am Acad Dermatol 24:915-926.
94. Luger TA, Stadler BM, Katz SI, Oppenheim JJ (1981). Epidermal cell keratinocyte-derived thymocyte-activating factor (ETAF). J Immunol 79:34-39.
95. Luger TA, Kock A, Kirnbauer R, Schwarz T, Ansel JC (1988). Keratinocyte derived interleukin-3. Ann NY Acad Sci USA 548:253-261.
96. Luger TA, Schwarz T, Krutmann J, Kirnbauer R, Neuner P, Kock A, et al. (1989a). Interleukin-6 is produced by epidermal cells and plays an important role in the activation of human T lymphocytes and natural killer cells. Ann NY Acad Sci USA 557:405-414.
97. Luger TA, Krutmann J, Kirnbauer R, Urbanski A, Schwarz T, Klappaker G, et al. (1989b). Interferon β2/IL-6 augments the activity of human natural killer cells. J Immunol 143:1200-1209.
98. Maciag T (1982). An endocrine approach to the control of epidermal growth: serum-free cultivation of human keratinocytes. Science 211:1452-1453.
99. MacNeil IA, Suda T, Moore KW, Momann TR, Zlotnik A (1990). IL-10, a novel growth factor for mature and immature T-cells. J Immunol 145:4167-4173.
100. Malmström M, Konttinen YT, Jungell P, Bergroth V, Segerberg-Konttinen M, Nordström D (1988). Lymphocyte activation in oral lichen planus in situ. Am J Clin Pathol 89:329-334.
101. Matsue H, Cruz PD, Bergstresser PR, Takashima A (1992). Langerhans cells are the major source of mRNA for IL-1β and MIP-1α among unstimulated mouse epidermal cells. J Invest Dermatol 99:537-541.
102. Matthews JB, Scully CM, Potts AJC (1984). Oral lichen planus: An immunoperoxidase study using monoclonal antibodies to lymphocyte subsets. Br J Dermatol 111:587-595.
103. Mizutani H, Black R, Kupper TS (1989). Post-translation modifications of IL-1 differ markedly in keratinocytes and monocytes: implications for epidermal biology (abstract). J Invest Dermatol 92:483.
104. Miller MD, Krangel MS (1992). Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17-46.
105. Muller G, Saloga J, Germann T, Bellinghausen I, Mohamadzadeh M, Knop J, et al. (1994). Identification and induction of human keratinocyte-derived IL-12. J Clin Invest 94:1799-1805.
106. Munger K, Pietenpol JA, Pittelkow MR, Holt JT, Moses HL (1992). Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ 3:291-298.
107. Muzio M, Re F, Sironi M, Polentarutti N, Minty A, Caput D, et al. (1994). Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood 83:1738-1743.
108. Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krenski AM (1993). Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151:2601-2612.
109. Nicola NA (1989). Hematopoietic cell growth factors and their receptors. Ann Rev Biochem 58:45-77.
110. Nickoloff BJ, Basham TY, Merigorn TC (1984). Antiproliferative effects of recombinant alpha and gamma interferons on cultured human keratinocytes. Lab Invest 51:697-673.
111. Niimura M (1990). Application of beta-interferon in virus-induced papillomas. J Invest Dermatol 95:1495-1515.
112. Nozaki S, Matic S, Abrams JS, Pearce MK, Sauder DN (1991). Augmentation of GM-CSF expression by ultraviolet irradiation is mediated by interleukin-1 in Pam 212 keratinocytes. J Invest Dermatol 99:10-14.
113. Nozaki S, Feliciani C, Sauder DN (1993). Keratinocyte cytokines. Dermatol 7:83-100.
114. Ohsaka A, Kitagawa S, Yuo A, Motoyoshi K, Furusawa S, Miura Y (1993). Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes. Clin Exp Immunol 91:308-313.
115. Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK (1986). There is more than one interleukin. J Immunol Today 7:45-55.
116. Paulsson Y, Hammacher A, Heldin C, et al. (1987). Possible positive autocrine feedback in the prereplicable phase of human fibroblasts. Nature 328:715-717.
117. Peetre C, Gullberg U, Nilsson E, Olsson I (1986). Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. J Clin Invest 78:1694-1701.
118. Pennica D, Shalaby MR, Palladino MB Jr (1987). Tumor necrosis factor alpha and beta. In: Recombinant lymphokines and their receptors. Gillis S, editor. New York: Marcel Dekker Inc., pp. 301-318.
119. Pestka S (1994). The interferons. In: Epidermal growth factors and cytokines. Luger TA, Schwarz T, editors. New York: Marcel Dekker, pp. 163-201.
120. Phillip R, Epstein LB (1986). Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323:86-90.
121. Pittelkow MR (1991). Growth factors in cutaneous biology and disease. Adv Dermatol 7:55-81.
122. Pittelkow MR, Shipley GD (1989). Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements. J Cell Physiol 140:565-576.
123. Pittelkow MR, Coffey RJ, Moses HL (1988). Keratinocytes produce and are regulated by transforming growth factors. Ann NY Acad Sci 258:211-224.
124. Resnick MB, Weller PF (1993). Mechanism of eosinophil recruitment. Am J Resp Cell Molec Biol 8:349-355.
125. Rich BE, Campos-Torres J, Tepper RI, Moreadith RW, Leder P (1993). Cutaneous lymphoproliferation and lymphomas in interleukin-7 transgenic mice. J Exp Med 177:305-316.
126. Rivas JM, Ullrich SE (1992). Keratinocyte-derived IL-10 (abstract). J Invest Dermatol 98:578.
127. Rocken M, Muller KM, Hauser C (1994). T-cell derived lymphokines. In: Epidermal growth factors and cytokines. Luger TA, Schwarz T, editors. New York: Marcel Dekker, pp. 131-145.
128. Roitt I, Brostaff J, Mak D (1993). Cell cooperation in the antibody response. In: Immunology. 3rd ed. St. Louis: C.V. Mosby, pp. 7.1-7.16.
129. Romagnani S (1995). Biology of human TH1 and TH2 cells. J Clin Immunol 15:121-129.
130. Rossi V, Breviario F, Ghezzi P (1985). Prostacyclin synthesis induced in vascular cells by interleukin-1. Science 229:174-176.
131. Rothe M (1989). Growth factors. Arch Dermatol 125:1390-1401.
132. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD (1991). A form of circulating ICAM-1 in human serum. J Immunol 147:3788-3793.
133. Rubin JS, Bottaro DP, Chedid M, Miki T, Ron D, Cheon G, et al. (1995). Keratinocyte growth factor. Cell Biol Int 19:399-411.
134. Sato M, Yoshida H, Yanagawa T, Yura Y, Urata M, Atsumi M, et al. (1984). Interferon activity and its characterization in the sera of patients with head and neck cancer. Cancer 54:1239-1251.
135. Sauder DN (1989). Interleukin-1. Arch Dermatol 125:679-682.
136. Sauder DN, Katz SI (1982). Immune modulation by epidermal cell products: possible role of ETAF in inflammatory and neoplastic skin diseases. J Am Acad Dermatol 7:651-654.
137. Scheurich P, Thomas B, Ücer U, Pfizenmaier K (1987). Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-α: induction of the receptors on human T-cells and TNF-α-mediated enhancement of T-cell responses. J Immunol 138:1786-1790.
138. Schmidt JA, Oliver CN, Lepe-Zuniga JL (1984). Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin-1. J Clin Invest 73:1462-1467.
139. Schleimer RP, Sterbinski SA, Kaiser J, Bickel CA, Tomioka K, Newman W, et al. (1992). IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148:1086-1092.
140. Schroder JM, Christofer E (1986). Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87:53-58.
141. Schroder JM, Peerson N, Christofer E (1990). Lipopolysaccharide-stimulated human monocytes secrete apart from NAP-1/IL-8 a second neutrophil activating protein: NH2-terminal aminoacid sequence identity with melanoma growth stimulatory activity (MGSA/gro). J Exp Med 171:1091-1100.
142. Seckinger P, Lowenthal JW, Williamson K, Dayer JM, MacDonald HR (1987). A murine inhibitor of interleukin-1 activity that blocks ligand binding. J Immunol 139:1546-1549.
143. Sebok B, Bonnekoh B, Mahrle G (1994). IL-1 alpha-induced expression of ICAM-1 on cultured hyperproliferative keratinocytes: suppression by antipsoriatic dimethyl-fumarate. Int J Dermatol 33:367-370.
144. Sieff CA (1987). Hematopoietic growth factors. J Clin Invest 79:1549-1557.
145. Shimada S (1994). T-cell receptor expression by dendritic epidermal T-cells. J Dermatol 21:829-832.
146. Spiegelberg HL (1990). Fc receptors for IgE and interleukin-4 induced IgE and IgG4 secretion. J Invest Dermatol 94:49s-52s.
147. Springer TA, Dustin ML, Kishimoto TK, Marlin SD (1987). The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Ann Rev Immunol 5:223-252.
148. Steinman RM (1991). The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 9:271-296.
149. Taga K, Tosato G (1992). IL-10 inhibits human T-cell proliferation and IL-2 production. J Immunol 148:1143-1148.
150. Tagari P, Pecheur EI, Scheid M, Brown P, Ford Hutchinson AW, Nicholson D (1993). Activation of human eosinophils and differentiated HL 60 cells by interleukin-5. Int Arch Allergy Appl Immunol 101:227-233.
151. Takeluchi Y, Tohnai I, Kaneda T, Nagura H (1988). Immunohistochemical analysis of cells in mucosal lesions of oral lichen planus. J Oral Pathol Med 17:367-373.
152. Tan EM, Qin H, Kennedy SH, Rouda S, Fox JW 4th, Moore JH Jr (1995). Platelet-derived growth factors-AA and -BB regulate collagen and collagenase gene expression differentially in human fibroblasts. Biochem 310:585-588.
153. Teunissen MB, Rongen HA, Bos JD (1994). Function of adhesion molecules lymphocyte function-associated antigen-3 and intercellular adhesion molecule-1 on human epidermal Langerhans cells in antigen-specific T-cell activation. J Immunol 152:3400-3409.
154. Teunissen MB, Koomen CW, Bos JD (1995). Intercellular adhesion molecule-3 (CD50) on human epidermal Langerhans cells participates in T-cell activation. J Invest Dermatol 104:995-998.
155. Thomas DW, Bagg J, Walker DM (1988). The in vitro cytotoxic effect of leukocytes from patients with recurrent aphthous ulceration upon mouse 3T3 fibroblasts. J Oral Pathol Med 17:421-425.
156. Thomas KA (1986). Fibroblast growth factor: broad spectrum mitogens with potent angiogenic activity. Trends Biochem Sci 11:81-86.
157. Thomson AW, Satoh S, Nüssler AK, Tamura K, Woo J, Gavaler J, et al. (1994). Circulating intercellular adhesion molecule-1 in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes. Clin Exp Immunol 95:83-90.
158. Thornhill MH, Kyan-Aung U, Haskard DO (1990). IL-4 increases endothelial cell adhesiveness for T-cells but not for neutrophils. J Immunol 144:3060-3065.
159. 2/interleukin-6 is a costimulant for human thymocytes and T-lymphocytes. J Immunol 141:1556-1562.
160. Tracey KJ, Vlassara H, Cerami A (1989). Cachectin/tumor necrosis factor. Lancet i:1122-1126.
161. Tron VA, Coughlin MD, Jang DE, Sauder DN (1990). The expression and modulation of nerve growth factor (NGF) in murine keratinocytes (PAM 212). J Clin Invest 85:1085-1089.
162. Tsujisaki M, Imai K, Hirata H, Hanzawa Y, Masuya J, Nakano T, et al. (1991). Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 85:3-8.
163. Turner M, Londei M, Feldmann M (1987). Human T-cells from autoimmune and normal individuals can produce tumor necrosis factor. Eur J Immunol 17:1807-1814.
164. Ueta E, Umazume M, Yamamoto T, Osaki T (1993). Leukocyte dysfunction in oral mucous membrane diseases. J Oral Pathol Med 22:120-125.
165. Vadhan-Raj S, Keating M, LeMaistre A, et al. (1987). Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317:1545-1552.
166. Van Snick J (1990). Interleukin-6: an overview. Ann Rev Immunol 8:253-278.
167. Venner TJ, Sauder DN, Feliciani C, McKenzie RC (1995). Interleukin-8 and melanoma growth stimulating activity (GRO) are induced by ultraviolet B radiation in human keratinocyte cell lines. Exp Dermatol 4:138-145.
168. Vyth-Dreese FA, Dellemjin TAM, Frijhoff A, VanKooyk Y, Figdor CG (1993). Role of LFA-1/ICAM-1 in interleukin-2 stimulated lymphocyte proliferation. Eur J Immunol 23:3292-3299.
169. Wahl SM (1988). Transforming growth factor beta is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation. J Immunol 140:3026-3031.
170. Wahl SM (1994). Regulation of tissue inflammation, repair, and fibrosis by transforming growth factor beta. In: Epidermal growth factors and cytokines. Luger TA, Schwatz T editors. New York: Marcel Dekker, pp. 241-252.
171. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB (1990). IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils in a leucocyte integrin (CD11/18) dependent manner. Immunology 71:258-265.
172. Wang M, Friedman H, Djeu JY (1989). Enhancement of human monocyte function agianst Candida albicans by the colony-stimulating factor (CSF): IL-3 granulocyte-macrophage CSF and macrophage-CSF. J Immunol 143:671-677.
173. Warringa RA, Schweizer RC, Maikoe T, Kuijper PH, Bruijnzeel PL, Koendermann L (1992). Modulation of eosinophil chemotaxis by interleukin-5. Am J Resp Cell Molec Biol 7:631-636.
174. Waterfield MD (1989). Altered growth regulation in cancer. Br Med Bull 45:570-581.
175. Wei S, Serbousek D, McMillen S, Blanchard DK, Djeu JY (1991). Suppression of human monocyte function against Candida albicans by autologous IL-2 induced lymphokine-activated killer cells. J Immunol 146:337-342.
176. Wickramasinghe L, Hindson TC, Wacks H (1989). Treatment of neoplastic skin lesions with intralesional interferon. J Am Acad Dermatol 20:71-74.
177. Wismer JM, McKenzie RC, Sauder DN (1994). Interleukin-8 immunoreactivity in epidermis of cutaneous T-cell lymphoma patients. Lymphokine Cytokine Res 13:21-27.
178. Wong GHW, Krowka JR Jr, Stites DP, Goeddel DV (1988). In vitro anti-human immunodeficiency virus activities of tumor necrosis factor alpha and interferon-gamma. J Immunol 140:120-126.
179. Yamamoto T, Osaki T (1995). Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 5:784-788.
180. Yamamoto T, Yoneda K, Ueta E, Hirota J, Osaki T (1991). Serum cytokine levels in patients with oral mucous membrane disorders. J Oral Pathol Med 20:275-279.
181. Yamamoto T, Osaki T, Yoneda K, Ueta E (1993). An immunological investigation on adult patients with primary herpes simplex virus-1 infection. J Oral Pathol Med 22:263-267.
182. Yamamoto T, Yoneda K, Ueta E, Osaki T (1994a). Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders. Oral Surg Oral Med Oral Pathol 78:727-735.
183. Yamamoto T, Osaki T, Yoneda K (1994b). Cytokine production by keratinocytes and mononuclear infiltrates in oral lichen planus. J Oral Pathol Med 23:309-315.
184. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, et al. (1987). Purification of a human monocyte-derived neutrophil chemotactic factor that shows sequence homology with other host defence cytokines. Proc Natl Acad Sci USA 84:9233-9239.